Systane Clinical Experience Study

To evaluate the physical effect of SYSTANE QID in people that have moderate to severe dry eyes and to establish doctor confidence to prescribe Systane.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dry Eye Syndrome Dry Eye Syndromes Eye Diseases Lacrimal Apparatus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

moderate to severe dry feeling eyes

Exclusion criteria

None

Treatment and study plan

Systane

Other

Systane prescription

Primary outcomes

corneal and conjunctiva staining score

Time frame: 4 weeks

Secondary outcomes

Tear film break up time

Time frame: 4 weeks

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Official study title

Study to Evaluate the Physical Effect of SYSTANE QID in People That Have Moderate to Severe Dry Feeling Eyes

Important dates

Study start: 2009
Primary completion: 2009
Study completion: 2009
First posted: Jan 8, 2009
Registry last updated: Feb 2, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed